Viewing Study NCT00425035


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2025-12-25 @ 7:46 PM
Study NCT ID: NCT00425035
Status: COMPLETED
Last Update Posted: 2013-05-13
First Post: 2007-01-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module